Risk and prevention of gastrointestinal complications due to low-dose aspirin and other antiplatelet agents;Accidents digestifs dus à la prise d'aspirine à faible dose et autres antiagrégants plaquettaires

Revue du Praticien

Volumn 58, Issue 13, 2008, Pages 1434-1440

  Bretagne, Jean François ^a  

^a UNIVERSITÉ DE RENNES 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; ANTIVITAMIN K; CLOPIDOGREL; CORTICOSTEROID; ESOMEPRAZOLE; ETORICOXIB; IBUPROFEN; LUMIRACOXIB; MISOPROSTOL; PLACEBO; PROTON PUMP INHIBITOR; ROFECOXIB; TICLOPIDINE;

ADJUVANT THERAPY; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COLON DIVERTICULOSIS; DRUG EFFECT; DRUG RESPONSE; FRANCE; GASTRODUODENAL ULCER; GASTROINTESTINAL HEMORRHAGE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; INCIDENCE; LOW DRUG DOSE; LOWER GASTROINTESTINAL BLEEDING; LOWER GASTROINTESTINAL HEMORRHAGE; MORTALITY; PEPTIC ULCER BLEEDING; REVIEW; RISK FACTOR; TREATMENT DURATION; UPPER GASTROINTESTINAL BLEEDING; ARTICLE; CHEMICALLY INDUCED DISORDER; GASTROINTESTINAL DISEASE;

ASPIRIN; GASTROINTESTINAL DISEASES; HUMANS; PLATELET AGGREGATION INHIBITORS; RISK FACTORS;

EID: 53049103615     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Thiéfin G, Montalescot G, Wolmant F, et al. Prévalence et caractéristiques du traitement par aspirine faible dose et de la gastroprotection associée: résultats d'une enquête postale en France. Gastroenterol Clin Biol 2008;32:A87.
2. Taha AS, Anderson WJ, Knill-Jones RP, Blatchford O. Upper gastrointestinal haemorrhage associated with low-dose aspirin and anti-thrombotic drugs - a 6-year analysis and comparison with non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther 2005;22:285-9.
3. Van Leerdam ME, Vreeburg EM, Rauws EA, et al. Acute upper GI bleeding: did anything change? Am J Gastroenterol 2003;98:1494-9.
4. Kang JY, Elders A, Majeed A, et al. Recent trends in hospital admissions and mortality rates for peptic ulcer in Scotland 1982-2002. Aliment Pharmacol Ther 2006;24:65-79.
5. Thiéfin G, Montalescot G, Wolmant F, et al. Prévalence et impact clinique des symptômes digestifs hauts chez les patients traités par aspirine faible dose. Gastroenterol Clin Biol 2008;32:A202.
6. Taha AS, Angerson WJ, Morran CG. Correlation between erosive œsophageal and gastroduodenal diseases. The influence of aspirin, simple analgesics, and Helicobacter pylori. Eur J Gastroenterol Hepatol 2002;14:1313-7.
7. Laine L. Review article: gastrointestinal bleeding with low-dose aspirin - what's the risk? Aliment Pharmacol Ther 2006;24:897-908.
8. Yeomans ND, Lanas AI, Talley NJ, et al. Prevalence and incidence of gastroduodenal ulcers during treatment with vascular protective doses of aspirin. Aliment Pharmacol Ther 2005;22:795-801.
9. Laine L, Maller ES, Yu C, Ouan H, Simon T. Ulcer formation with low-dose enteric-coated aspirin and the effect of COX-2 selective inhibition: a double-blind trial. Gastroenterology 2004;127:395-402.
10. García Rodríguez LA, Hernández-Díaz S. Risk of uncomplicated peptic ulcer among users of aspirin and nonaspirin nonsteroidal antiinflammatory drugs. Am J Epidemiol 2004;159:23-31.
11. Nalet B, Bretagne JF, Lesur G, et al. Hémorragies digestives et antiagrégants plaquettaires. Enquête observationnelle hospitalière nationale portant sur 1010 malades. Gastroenterol Clin Biol 2008;32:A101.
12. Bretagne JF, Nalet B, Lesur G, et al. Caractéristiques des hémorragies digestives survenant sous antiagrégants plaquettaires. Étude prospective d'une cohorte hospitalière multicentrique de 297 malades. Gastroenterol Clin Biol 2008;32:A204.
13. McQuaid KR, Laine L. Systematic review and meta-analysis of adverse events of low-dose aspirin and clopidogrel in randomized controlled trials. Am J Med 2006;119:624-38.
14. Ibanez L, Vidal X, Vendrell L, et al. Upper gastrointestinal bleeding associated with antiplatelet drugs. Aliment Pharmacol Ther 2006;25:235-42.
15. Serrano P, Lanas A, Arroyo MT, Ferreira IJ. Risk of upper gastrointestinal bleeding in patients taking low-dose aspirin for the prevention of cardiovascular diseases. Aliment Pharmacol Ther 2002;16:1945-53.
16. Sørensen HT, Mellemkjær L, Blot WJ, et al. Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin. Am J Gastroenterol 2000;95:2218-24.
17. Lanas A, Perez-Aisa MA, Feu F, et al. A nationwide study of mortality associated with hospital admission due to severe gastrointestinal events and those associated with nonsteroidal antiinflammatory drug use. Am J Gastroenterol 2005;100:1685-93.
18. García Rodríguez LA, Hernández-Díaz S, de Abajo FJ. Association between aspirin and upper gastrointestinal complications: systematic review of epidemiologic studies. Br J Clin Pharmacol 2001;52:563-71.
19. Van Oijen MG, Dieleman JP, Laheij RJ, Sturkenboom MC, Jansen JB, Verbeugt FW. Peptic ulcerations are related to systemic rather than local effects of low-dose aspirin. Clin Gastroenterol Hepatol 2008;6:309-13.
20. Hallas J, Dall M, Andries A, et al. Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population based case-control study. BMJ 2006;333:726.
21. Strand V. Are COX-2 inhibitors preferable to non-selective non-steroidal anti-inflammatory drugs in patients with risk of cardiovascular events taking low-dose aspirin. Lancet 2007;370:2138-51.
22. Lanas A, García-Rodríguez LA, Arroyo MT, et al. Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non steroidal anti-inflammatory drugs, aspirin and combinations. Gut 2006;55:1731-8.
23. Yuan Y, Tsoi K, Hunt RH. Selective serotonin reuptake inhibitors and risk of upper GI bleeding: confusion or confounding? Am J Med 2006;119:719-27.
24. Lanas A, Bajador E, Serrano P, et al. Nitrovasodilators, low-dose aspirin, other nonsteroidal antiinflammatory drugs, and the risk of upper gastrointestinal bleeding. N Engl J Med 2000;343:834-9.
25. Patrono C, García Rodríguez LA, Landolfi R, Baigent C. Low-dose aspirin for the prevention of atherothrombosis. N Engl J Med 2005;353:2373-83.
26. Hernández-Díaz S, García-Rodríguez LA. Cardioprotective aspirin users and their excess risk of upper gastrointestinal complications. BMC Medicine 2006;4:22.
27. Lai KC, Lam SK, Chu KM, et al. Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use. N Engl J Med 2002;346:2033-8.
28. Agence française de sécurité sanitaire des produits de santé. Les antisécrétoires gastriques chez l'adulte (Recommandations de bonne pratique, Afssaps novembre 2007. http://agmed.sante.gouv.fr/pdf/5/rbp/antisecretoire-gastrique-reco.pdf.
29. Napoléon B, Boneu B, Maillard L, et al. Guidelines of the French Society for Digestive Endoscopy: management of patients on anticoagulants or antiplatelet agents before digestive endoscopy. Endoscopy 2006;38:632-8.
30. Sung J, Lau J, Ching J, et al. Can aspirin be reintroduced with proton pump inhibitor infusion after endoscopic hemostasis? A double blinded randomized controlled trial. Gastroenterology 2006;130:A-44.
31. Lanas A, García-Rodríguez LA, Arroyo MT, et al. Effect of antisecretory drugs and nitrates on the risk of ulcer bleeding associated with nonsteroidal anti-inflammatory drugs, antiplatelets agents, and anticoagulants. Am J Gastroenterol 2007;102:507-15.
32. Yeomans ND, Lanas A, Labenz J, et al. Prevention of low-dose aspirin-associated gastroduodenal ulcers and upper gastrointestinal symptoms in patients receiving esomeprazole 20 mg per day. Gastroenterology 2006;130:A-81.
33. Chan FK, Ching JY, Hung LC, et al. Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding. N Engl J Med 2005;352:238-44.
34. Lai KC, Chu KM, Hui WM, et al. Esomeprazole with aspirin versus clopidogrel for prevention of recurrent gastrointestinal ulcer complications. Clin Gastroenterol Hepatol 2006;4:860-5.